A Short Runway to Secure a Co-lead Investor
Coastar Therapeutics faced a unique challenge, navigating a short runway to secure a co-lead investor for their promising biological payload delivery technology. With time constraints and high expectations, finding the right partner on favorable terms was imperative to accelerate their mission.
Charting a Course to Accelerated Success
Our collaboration with Coastar Therapeutics underscores our dedication to overcoming unique challenges. We embarked on a tailored journey to identify and secure a co-lead investor who recognizes the transformative potential of Coastar's ENHEnSTM technology and shares their commitment to advancing cancer immunotherapy and gene therapies.